Bristol-Myers Squibb
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio0 active
3Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Grail
20Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Grail | Medtech | Public | Nov 7, 2025 | $1.7B |
| Karuna Therapeutics | Biotech | Acquired | — | — |
| Turning Point Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#136
Portfolio exits#69
Raises, 12 months#22
Co-investors#105
Co-investors
- Omega FundsVenture capital2 shared
- Bay City CapitalVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
- Boxer CapitalVenture capital1 shared
- Breakthrough Energy VenturesVenture capital1 shared
- Brookside CapitalVenture capital1 shared
- Clarus VenturesVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
- Gilead SciencesVenture capital1 shared
Sectors
- Biotech2
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.